Dizlin Competitors and Similar CompaniesClear all
Addex Therapeutics's competitors and similar companies include IRLAB Therapeutics.
 Addex Therapeutics Addex Therapeutics, a development-stage biopharmaceutical company, discovers small-molecule pharmaceutical products. |  IRLAB Therapeutics IRLAB Therapeutics is a biotechnology company focused on Parkinson's disease (PD). | |
Founding Date | Founding Date 2002 | Founding Date 2013 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Plan-les-Ouates, CH HQ San Francisco, US | Locations Göteborg, SE HQ |
Employees | Employees 23 | Employees 30 |
Financial | ||
Revenue (est.) | Revenue (est.) CHF30k (FY, 2025) | Revenue (est.) kr57.5m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit CHF173k (FY, 2025) | Gross profit kr62.8m (FY, 2025) |
Net income | Net income (CHF6.8m) (FY, 2025) | Net income (kr110m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
IRLAB Therapeutics
HQ
Göteborg, SE
Employees
30
IRLAB Therapeutics is a biotechnology company focused on Parkinson's disease (PD).
View company